Docket Room
H 4489·MA·house

An Act to ensure affordable prescription medications through accountability standards

Reported by CommitteeFiled Sep 18, 2025
Sponsor: Joint Committee on Financial Services
Latest Action

House: Reporting date extended to Friday, July 31, 2026

Jun 17, 2026

Summary

The bill forces manufacturers of certain prescription drugs to provide the state commission with detailed pricing history, research spending and explanations for price changes. The commission can then decide if a drug’s price is unreasonable, issue public recommendations to make the drug cheaper, and impose a civil penalty for non‑compliance. It targets drug makers, patients, health‑care providers and insurers by increasing transparency and accountability.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when H 4489 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice